IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils

Cytokine. 1996 Feb;8(2):147-51. doi: 10.1006/cyto.1996.0021.

Abstract

The anti-inflammatory properties of IL-4, IL-10, IL-13 and TGF-beta are associated with their ability to repress the production of pro-inflammatory cytokines and to favour the release of interleukin-1 receptor antagonist (IL-1ra). Here, we investigate their actions on activated human polymorphonuclear cells (PMN). IL-4 and TGF-beta were able to increase the production of IL-1ra, however only IL-4 were able to further increase IL-1ra production in the presence of LPS. When IL-1ra production by PMN was induced by tumour necrosis factor-alpha (TNF-alpha), IL-10 and IL-4 both amplified its release and its presence as a cell-associated form. In conclusion, IL-10 which was unable to induce IL-1ra by itself or to amplify the LPS-induced production by PMN, was able to increase its release when TNF-alpha, is the triggering signal. IL-4 was active in the different combinations tested; IL-13 and TGF-beta did not further modulate LPS- and TNF-alpha-induced IL-1ra production by PMN.

MeSH terms

  • Cells, Cultured
  • Drug Synergism
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1*
  • Interleukin-10 / pharmacology*
  • Interleukin-4 / pharmacology*
  • Lipopolysaccharides / pharmacology
  • Neutrophils / drug effects*
  • Neutrophils / metabolism
  • Recombinant Proteins / pharmacology
  • Reference Values
  • Sialoglycoproteins / biosynthesis*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Lipopolysaccharides
  • Recombinant Proteins
  • Sialoglycoproteins
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interleukin-4